What is the appropriate treatment for a 67-year-old patient with severe anxiety who is only taking hydroxyzine as needed (prn) for the past 14 days?

Treatment Recommendation for 67-Year-Old with Severe Anxiety on PRN Hydroxyzine

This patient requires immediate transition from hydroxyzine PRN to scheduled SSRI therapy, specifically starting with sertraline or escitalopram, as hydroxyzine is not appropriate for ongoing management of severe anxiety in older adults and carries significant risks in this age group.

Why Hydroxyzine Must Be Discontinued

Hydroxyzine is explicitly cautioned against in elderly patients for several critical reasons 1:

• Sedation and confusion risk: Sedating drugs cause confusion and over-sedation in the elderly; elderly patients should be started on low doses and observed closely
• QT prolongation: Cases of QT prolongation and Torsade de Pointes reported, particularly concerning in older adults with cardiac risk factors
• Cognitive impairment: Can worsen mental status in this age group
• Not evidence-based: Recent 2024 research specifically recommends caution with hydroxyzine for acute treatment in older adults with anxiety 2

The fact that this patient has been using hydroxyzine for 14 days without adequate control of "severe" anxiety confirms treatment failure.

First-Line Treatment: SSRIs

Start sertraline 25 mg daily OR escitalopram 5 mg daily 2, 3:

Sertraline or Escitalopram are preferred because:

• Strongest evidence base for anxiety disorders in adults 3
• Lower drug interaction potential: Escitalopram/citalopram have least effect on CYP450 enzymes compared to other SSRIs 4
• Favorable tolerability in older adults 2
• Sertraline specifically if sexual side effects are less concerning; escitalopram if minimizing drug interactions is priority

Dosing Strategy for Age 67:

1. Start low: Sertraline 25 mg daily or escitalopram 5 mg daily (half the typical adult starting dose) 2
2. Go slow: Increase by 25 mg sertraline or 5 mg escitalopram every 1-2 weeks as tolerated 4
3. Target dose: Sertraline 50-150 mg daily or escitalopram 10-20 mg daily
4. Timeline: Allow 4-6 weeks at therapeutic dose before assessing full response

Critical Prescribing Considerations:

Initial anxiety worsening: SSRIs can initially exacerbate anxiety 4. Starting with subtherapeutic "test dose" helps adherence and allows patient to adjust.

Bridge therapy consideration: While guidelines generally caution against benzodiazepines in elderly 5, if anxiety is truly severe and impairing function, consider lorazepam 0.25-0.5 mg twice daily for maximum 2-4 weeks only while SSRI takes effect 6. This is time-limited and must be tapered as SSRI becomes effective.

Second-Line Options (If SSRI Fails)

If inadequate response after 6-8 weeks at therapeutic SSRI dose 2:

1. Switch to different SSRI (e.g., sertraline to escitalopram or vice versa)
2. Switch to SNRI: Venlafaxine XR 37.5 mg daily or duloxetine 30 mg daily 3, 2
3. Consider buspirone 7.5 mg twice daily if avoiding sexual side effects is priority and patient is relatively healthy 2

Third-Line Options

If two adequate trials fail 2:

• Pregabalin 75-150 mg twice daily (start 25-50 mg twice daily)
• Gabapentin 300-900 mg daily in divided doses
• Quetiapine 25-50 mg at bedtime (use cautiously given antipsychotic risks in elderly)

What NOT to Do

Avoid benzodiazepines for chronic management 5:

• High-risk in elderly per Beers Criteria
• Cognitive impairment, falls, fractures, dependence
• If patient already on chronic benzodiazepine, taper gradually (25% reduction weekly minimum, often slower) 5

Avoid hydroxyzine continuation 1, 2:

• Not evidence-based for severe anxiety
• Excessive sedation risk in elderly
• Recent study showed no benefit over placebo for anxiety 7

Monitoring Requirements

• Week 1-2: Assess tolerability, side effects, adherence
• Week 4: Assess early response, consider dose increase if tolerated
• Week 6-8: Assess full response at therapeutic dose
• Ongoing: Monitor for suicidal ideation (though risk lower in elderly), falls, cognitive changes

Non-Pharmacologic Augmentation

While initiating SSRI, strongly recommend cognitive behavioral therapy (CBT) 3:

• Individual CBT specifically designed for anxiety disorders shows strong evidence
• Can be delivered by skilled therapist following structured protocol
• Combination therapy may be superior to monotherapy, though evidence in elderly is limited 4

Common Pitfalls to Avoid

1. Starting full adult doses: Always start at half-dose in elderly to minimize side effects and improve adherence
2. Premature discontinuation: Patients may stop due to initial anxiety worsening—education about this is critical
3. Inadequate trial duration: Must allow 6-8 weeks at therapeutic dose before declaring failure
4. Continuing hydroxyzine long-term: This is not appropriate treatment for severe anxiety in any age group
5. Reflexive benzodiazepine prescription: While tempting for immediate relief, creates more problems than it solves in elderly patients

The bottom line: Transition immediately to scheduled SSRI therapy (sertraline 25 mg or escitalopram 5 mg daily), discontinue hydroxyzine PRN, and refer for CBT if available.